Cargando…
Carvedilol in the treatment of elderly patients with chronic heart failure
Chronic heart failure (CHF) is common, and increases in incidence and prevalence with age. There are compelling data demonstrating reduced mortality and hospitalizations with adrenergic blockade in older patients with CHF. Despite this, many older patients remain under-treated. The aim of the presen...
Autores principales: | Witte, Klaus KA, Clark, Andrew L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2544370/ https://www.ncbi.nlm.nih.gov/pubmed/18488879 |
Ejemplares similares
-
Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial
por: Kveiborg, Britt, et al.
Publicado: (2007) -
Effect of beta‐adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial
por: Clark, Andrew L., et al.
Publicado: (2017) -
Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial
por: Düngen, Hans-Dirk, et al.
Publicado: (2011) -
Carvedilol in hypertension treatment
por: Stafylas, Panagiotis C, et al.
Publicado: (2008) -
Carvedilol, Bisoprolol, and Metoprolol Use in Patients With Coexistent Heart Failure and Chronic Obstructive Pulmonary Disease
por: Su, Vincent Yi-Fong, et al.
Publicado: (2016)